Rafael H. Lander Delgado

发表

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

T. Ziemssen, N. Tubridy, J. Frederiksen, 2014, Journal of Neurology.

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

T. Ziemssen, N. Tubridy, J. Frederiksen, 2014, Journal of Neurology.